Electrical storm in patients with an implantable defibrillator: Incidence, features, and preventive therapy: Insights from a randomized trial

European Heart Journal

Volumn 27, Issue 24, 2006, Pages 3027-3032

  Hohnloser, Stefan H ^a   Al Khalidi, Hussein R ^b   Pratt, Craig M ^c   Brum, Jose M ^b   Tatla, Daljit S ^b   Tchou, Patrick ^d   Dorian, Paul ^e  

^a GOETHE UNIVERSITY   (Germany)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Antiarrhythmic therapy; Azimilide dihydrochloride; Implantable cardioverter defibrillator; Ventricular tachycardia storms

Indexed keywords

AZIMILIDE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DRUG DOSE COMPARISON; DRUG WITHDRAWAL; ELECTRICAL STORM; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; RISK FACTOR; RISK REDUCTION; STATISTICAL SIGNIFICANCE;

ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; IMIDAZOLIDINES; MALE; MIDDLE AGED; PIPERAZINES; PROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 33845613684     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl276     Document Type: Article

References (17)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996;335:1933-1940.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
3. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs. Implantable Defibrillator Study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-2078.
4. DiMarco JP. Implantable cardioverter-defibrillators. N Engl J Med 2003;349:1836-1847.
5. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverterdefibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 1998;32:1909-1915.
6. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Europace 2000;2:263-269.
7. Exner DV, Pinski SL, Wyse DG, Renfroe EG, Follmann D, Gold M, Beckman KJ, Coromilas J, Lancaster S, Hallstrom AP, AVID Investigators. Antiarrhythmics versus implantable defibrillators. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001;103:2066-2071.
8. Pinski SL. Emergencies related to implantable cardioverter- defibrillators. Crit Care Med 2000;28(suppl.):N174-N180.
9. Irvine J, Dorian P, Baker B, O'Brien B, Roberts R, Gent M, Newman D, Connolly S. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-289.
10. Dorian P, Borggrefe M, Al-Khalidi HR, Hohnloser SH, Brum JM, Tatla DS, Brachmann J, Myerburg RJ, Cannom DS, van der Laan M, Holroyde MJ, Singer I, Pratt C, SHock Inhibition Evaluation with azimiLiDe (SHIELD) Investigators. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110:3646-3654.
11. Karam R, Marcello S, Brooks RR, Corey AE, Moore A. Azimilide dihydrochloride, a novel antiarrhythmic agent. Am J Cardiol 1998;81:40D-46D.
12. Lin DY, Wei LJ, Yang I, Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J Royal Stat Soc, Series B 2000;62:711-730.
13. Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Annals of Statistics 1982;10:1100-1120.
14. Cook RJ, Lawless JF, Nadeau C. Robust tests for treatment comparisons based on recurrent event responses. Biometrics 1996;52:557-571.
15. Bansch D, Böcker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardia signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol 2000;36:566-573.
16. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, Burkhardt JD, Belden WA, Cummings JE, Abdul-Karim A, Saliba W, Schweikert RA, Tchou PJ, Martin DO, Natale A. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004;15:1265-1270.
17. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000;102:742-747.